in Vitro Fertilization Clinical Trial
Official title:
Optimal rhCG(Ovidrel®) Dose for Final Oocyte Maturation Triggering in Poor Responder During IVF and ICSI Cycles
Choriogonadotropin alfa (Ovidrel®) is a recombinant hCG (rhCG) preparation derived from genetically engineered Chinese hamster ovary cells, which is widely used for final oocyte maturation triggering in assisted reproductive technology (ART).Recombinant hCG has been investigated about its safety and efficacy comparing with urinary hCG, but still the optimal dose of rhCG is questionable. From former studies, there only have been proven that high dose of hCG can make ovarian hyperstimulation syndrome (OHSS) in usual condition. On the other hand, we hypothesize that high dose of hCG may improve oocyte maturity in poor responders who cannot easily provoke OHSS. Hence, this study will assess the comparative efficacy and safety of 250mcg and 500mcg of rhCG in ART treatment cycle.
Randomized prospective clinical study that compare the two doses of rhCG (250mcg vs. 500mcg). ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00696878 -
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
|
Phase 3 | |
| Recruiting |
NCT04122729 -
N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS
|
||
| Not yet recruiting |
NCT02534857 -
A Study Comparing a Shorter Exposure of Oocyte to Spermatozoa Versus a Standard Incubation on the Live Birth Rate of In-vitro Fertilization Treatment
|
N/A | |
| Completed |
NCT01406028 -
Does Emotional Support Decrease In Vitro Fertilization Stress?
|
N/A | |
| Withdrawn |
NCT00541892 -
Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine
|
Phase 2 | |
| Completed |
NCT00708383 -
in Vitro Fertilization (IVF) Media Protein and Live Birth Rates
|
N/A | |
| Completed |
NCT03627533 -
The Differences of Oocyte Maturation, Granulosa Cell Apoptosis Index Between Electroacupuncture And Sham Groups IVF
|
N/A | |
| Recruiting |
NCT04160611 -
What Amount of Stress is Enough for a Successful Conception?
|
Phase 3 | |
| Suspended |
NCT01600794 -
To Evaluate The Anrogens and Ovary Function in In Vitro Fertilization
|
N/A | |
| Completed |
NCT01507376 -
Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity
|
Phase 3 | |
| Terminated |
NCT00866008 -
A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)
|
Phase 4 | |
| Recruiting |
NCT04082650 -
Vitamin D and Pregnancy Outcome in PCOS Patients
|
N/A | |
| Recruiting |
NCT03758833 -
eSET or eDET Associated to PGT in IVF
|
N/A | |
| Not yet recruiting |
NCT04407871 -
Acupuncture and Chinese Herbal Medicine to Improve Live Birth Rate of in Vitro Fertilization (IVFAct)
|
N/A | |
| Recruiting |
NCT03345030 -
The Role of DNA Damage of Granulosa Cell on Oocyte Quality and in Vitro Fertilization Outcome
|
N/A | |
| Not yet recruiting |
NCT03090438 -
IVF Outcomes After Varicocele Repair
|
N/A | |
| Terminated |
NCT01614067 -
Delayed Start to Ovarian Stimulation
|
Phase 4 | |
| Completed |
NCT01343992 -
Bed Rest or no Bed Rest?
|
N/A | |
| Completed |
NCT00557687 -
Prediction of Ovarian Response
|
N/A | |
| Completed |
NCT03428165 -
Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate
|
N/A |